Research in Oncology

Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Research in Oncology is an open-access journal published by Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine in Egypt, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 170 USD. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine
ISSN
2357-0687 · 2357-0695
Country
Egypt
Languages
english
Access
Open access
Declared publication charge
170 USD
Articles in DOAJ
100
Declared review time
8 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2020-06-08
Indexing
DOAJ
APC
170 USD
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

100

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

239

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

5

i10-index

3

From OpenAlex open data (CC0).

Editorial & policy9
Last DOAJ review date
2020-06-08
Added to DOAJ
2020-06-08
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Head and Neck Cancer Studies
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques
  • Head and Neck Cancer Studies
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
Show all subjects (50)
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Advanced Breast Cancer Therapies
  • Lung Cancer Research Studies
  • Advanced Breast Cancer Therapies
  • Lung Cancer Research Studies
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Glioma Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Advances in Oncology and Radiotherapy
  • Brain Metastases and Treatment
  • Advances in Oncology and Radiotherapy
  • Bladder and Urothelial Cancer Treatments
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Bladder and Urothelial Cancer Treatments
  • Brain Metastases and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • Sarcoma Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Cancer Risks and Factors
  • Management of metastatic bone disease
  • Urinary and Genital Oncology Studies
  • Cancer Genomics and Diagnostics
  • Management of metastatic bone disease
  • Cancer Risks and Factors
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Cancer Genomics and Diagnostics
  • Urinary and Genital Oncology Studies
  • Breast Lesions and Carcinomas
  • Breast Lesions and Carcinomas

Keywords (DOAJ)

  • oncology
  • cancer
  • neoplasm
  • carcinogenesis
  • cancer therapy
  • supportive care

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: